Loxo Oncology, Inc. (LOXO) [Rocket]

In millions, except per share items	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13
	10-K	10-K	10-K	10-K	10-K
Revenue from collaboration agreement	21.3

Operating expenses:
Research and development	140.0	58.3	14.0	6.9
General and administrative	33.7	14.9	10.5	6.2
Total operating expenses	173.7	73.2	36.1
Loss from operations	-152.4	-73.2	-36.1	-20.7
Interest income, net	3.5	0.8	0.2	0.0
Net loss	-148.9	-72.4	-35.9	-20.7

Per share information:
Net loss per share of common stock, basic and diluted (in dollars per share)	($5.31)	($3.46)	($2.12)	($3.06)

Weighted average shares outstanding, basic and diluted diluted (in shares)	28.0	20.9	16.9	6.8